321
Views
6
CrossRef citations to date
0
Altmetric
Research Articles

Integrating biopharmaceutics risk assessment and in vivo absorption model in formulation development of BCS class I drug using the QbD approach

, &
Pages 668-677 | Received 01 Aug 2016, Accepted 19 Dec 2016, Published online: 22 Jan 2017

References

  • Selen A, Cruañes MT, Müllertz A, et al. Meeting report: applied biopharmaceutics and quality by design for dissolution/release specification setting: product quality for patient benefit. AAPS J 2010;12:465–72.
  • Wright DF, Winter HR, Duffull SB. Understanding the time course of pharmacological effect: a PKPD approach. Br J Clin Pharmacol 2011;71:815–23.
  • Selen A, Dickinson PA, Mullertz A, et al. The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performance. J Pharm Sci 2014;103:3377–97.
  • Yu LX, Amidon G, Khan MA, et al. Understanding pharmaceutical quality by design. AAPS J 2014;16:771–83.
  • Kubbinga M, Langguth P, Barends D. Risk analysis in bioequivalence and biowaiver decisions. Biopharm Drug Dispos 2013;34:254–61.
  • United States Pharmacopoeial Convention, Inc. USP35-NF30. Method <616> Bulk and tap density of powders. Rockville (MD): 12601 Twinbrook Parkway; 2011: 5637–40.
  • United States Pharmacopoeial Convention, Inc. USP 36-NF 31. Rockville (MD); 2013: 3592–94.
  • United States Pharmacopoeial Convention, Inc. USP 32-NF 27. <905> Uniformity of dosage units. Rockville (MD); 2009: 3592–94.
  • Charoo NA, Cristofoletti R, Graham A, et al. Biowaiver monograph for immediate-release solid oral dosage forms: fluconazole. J Pharm Sci 2014;103:3843–58.
  • Cristofoletti R, Charoo NA, Dressman JB. Exploratory investigation of the limiting steps of oral absorption of fluconazole and ketoconazole in children using an in silico pediatric absorption model. J Pharm Sci 2016;105:2794–803.
  • Jamei M, Turner D, Yang J, et al. Population-based mechanistic prediction of oral drug absorption. AAPS J 2009;11:225–37.
  • Summary of product characteristics. Diflucan 200 mg hard capsules, Pfizer Limited; 2013. Available from: http://www.medicines.org.uk/emc/medicine/25675/SPC/Diflucan±200±mg±hard±capsules/ [Accessed 1 Sept 2013].
  • Charoo NA, Cristofoletti R, Dressman JB. Risk assessment for extending the biopharmaceutics classification system-based biowaiver of immediate release dosage forms of fluconazole in adults to the paediatric population. J Pharm Pharmacol 2015;67:1156–69.
  • European Medicines Evaluation Agency (EMEA), Committee for Proprietary Medicinal Products (CPMP). Note for guidance on the investigation of bioavailability and bioequivalence; 2001. Available from: http://www.emea.eu.int/pdfs/human/ewp/140198en.pdf [Accessed 9 Sept 2013].
  • Alkhamis KA, Obaidat AA, Nuseirat AF. Solid-state characterization of fluconazole. Pharm Dev Technol 2002;7:491–503.
  • Park HJ, Kim MS, Kim JS, et al. Solid-state carbon NMR characterization and investigation of intrinsic dissolution behavior of fluconazole polymorphs, anhydrate forms I and II. Chem Pharm Bull 2010;58:1243–7.
  • Modha NB, Chotai NP, Patel VA, Patel BG. Preparation, characterization and evaluation of fluconazole polymorphs. Int J Res Pharm Biomed Sci 2010;1:124–7.
  • Desai SR, Dharwadkar SR. Study of process induced polymorphic transformations in fluconazole drug. Acta Pol Pharm Drug Res 2009;66:115–22.
  • Obaidat RM, Alkhamis KA, Salem MS. Determination of factors affecting kinetics of solid-state transformation of fluconazole polymorph II to polymorph I using diffuse reflectance Fourier transform spectroscopy. Drug Dev Ind Pharm 2010;36:570–80.
  • Blum RA, D’Andrea DT, Florentino BM, et al. Increased gastric pH and the bioavailability of fluconazole and ketoconazole. Ann Intern Med 1991;114:755–7.
  • Aulton ME. Pharmaceutics: the science of dosage form design. 2nd edn. United Kingdom: Churchill Livingstone; 2002: 528–31.
  • Peters HJW. Lactose for direct compression. Chemical Weekly December 22. 2009. Available from: http://www.signetchem.com/downloads/datasheets/Domo/Lactose-for-Direct-Compression.pdf
  • Augsburger LL. Hard and soft shell capsules. In: Florence AT, Siepmann J, eds. Modern Pharmaceutics. 5th edn. Vol. 1. Basic principles and systems. 52 Vanderbilt Avenue, New York (NY): Informa Healthcare USA, Inc.; 2009: 10017.
  • Newton JM, Rowley G, Tornblom JFV. The effect of additives on the release of drug from hard gelatin capsules. J Pharm Pharmacol 1971;23:452–3.
  • Withey RJ, Mainville CA. A critical analysis of a capsule dissolution test. J Pharm Sci 1969;58:1120–6.
  • Koparkar AD, Augsburger LL, Shangraw RF. Intrinsic dissolution rates of tablet filler-binders and their influence on the dissolution of drugs from tablet formulations. Pharm Res 1990;7:80–6.
  • Moolchandani V. Functionality and performance of different lactose grades. In: Capsule filling: characterization and evaluation of formulation and operating variables on dosing disc machines. Baltimore: University of Maryland; 2010.
  • Amidon GE. Intrinsic properties of drug substance, excipients, and process selection. FDA OGD regulatory science training series. Manufacturing science and scale-up challenges. May 23, 2005.
  • Aguilar-Díaz JE, García-Montoya E, Pérez-Lozano P, et al. The use of the SeDeM diagram expert system to determine the suitability of diluents-disintegrants for direct compression and their use in formulation of ODT. Eur J Pharm Biopharm 2009;73:414–23.
  • Hussain MSH, York P, Timmins P, Humphrey P. Secondary ion mass spectrometry (SIMS) evaluation of magnesium stearate distribution and its effects on the physic-technical properties of sodium chloride tablets. Powder Technol 1990;60:39–45.
  • Cristofoletti R, Chiann C, Dressman JB, Storpirtis S. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies. J Pharm Sci 2013;102:3136–44.
  • Tan SB, Newton JM. Powder flowability as an indication of capsule filling performance. Int J Pharm 1990;61:145–55.
  • Ahmed H, Shah N. Formulation of low dose medicines—theory and practice. Am Pharm Rev 2000;3:9–15.
  • Gohil UC, Podczeck F, Turnbull N. Investigations into the use of pregelatinised starch to develop powder-filled hard capsules. Int J Pharm 2004;285:51–63.
  • Podczeck F. Investigations into the reduction of powder adhesion to stainless steel surfaces by surface modification to aid capsule filling. Int J Pharm 1999;178:93–100.
  • Cho HY, Kang HA, Lee S, et al. Bioequivalence of flucona capsule to Diflucan capsule (falfluconazole 50 mg). J Kor Pharm Sci 2003;33:135–40.
  • Chowhan ZT, Chi LH. Drug-excipient interactions resulting from powder mixing. III: solid state properties and their effect on drug dissolution. J Pharm Sci 1986;75:534–41.
  • Alexander AW, Shinbrot T, Muzzio FJ. Granular segregation in the double cone blender: transitions and mechanisms. Phys Fluids 2001;13:578.
  • Liss E, Conway SL, Zega JA, Glasser BJ. Segregation of powders during gravity flow through vertical pipes. Pharm Tech 2004;28:78–96.
  • Conway SL, Lekhal A, Khinast JG, Glasser BJ. Granular flow and segregation in a four-bladed mixer. Chem Eng Sci 2005;60:7091–107.
  • Liss E, Glasser BJ. The influence of cluster formation on the stress in a sheared granular material. Powder Tech 2001;116:116–32.
  • Osorio JG, Muzzio FJ. Effects of powder flow properties on capsule filling weight uniformity. Drug Dev Ind Pharm 2013;39:1464–75.
  • Bergum JS, Prescott JK, Tejwani RW, et al. Current events in blend and content uniformity. Pharm Eng 2014;34:1–10.
  • Faulhammer E, Llusa M, Radeke C, et al. The effects of material attributes on capsule fill weight and weight variability in dosator nozzle machines. Int J Pharm 2014;471:332–8.
  • Uğurlu T, Turkoglu M. Hexagonal boron nitride as a tablet lubricant and a comparison with conventional lubricants. Int J Pharm 2009;353:45–51.
  • Mehta AM, Augsburger LL. A preliminary study of the effect of slug hardness on drug dissolution from hard gelatin capsules filled on an automatic capsule filling machine. Int J Pharm 1981;7:327.
  • Leonardi D, Salomon CJ. Influence of water uptake, gel network, and disintegration time on prednisone release from encapsulated solid dispersions. Pharm Dev Technol 2010;15:184–91.
  • Liusa M, Faulhammer E, Biserni S, et al. The effect of capsule-filling machine vibrations on average fill weight. Int J Pharm 2013;454:381–7.
  • Armstrong NA. The instrumentation of capsule-filling machinery. In: Watt PR, Armstrong NA, eds. Tablet and capsule machine instrumentation. London: Pharmaceutical Press; 2007: 207–22.
  • Shah KB, Augsburger LL, Marshall K. An investigation of some factors influencing plug formation and fill weight in a dosing disk-type automatic capsule-filling machine. J Pharm Sci 1986;75:291–6.
  • Shah KB, Augsburger LL, Marshall K. Multiple tamping effects on drug dissolution from capsules filled on a dosing-disk type automatic capsule filling machine. J Pharm Sci 1987;76:639–45.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.